• SERCA-ER Stress in HSC Mobilization

  2026-08-07

  Li et al. identify SERCA-mediated endoplasmic reticulum stress as a previously underused route for enhancing hematopoietic stem cell mobilization. Using pharmacological inhibition, genetic validation, in vivo mobilization assays, and pathway analysis, the study links BHQ activity to the CaMKII-STAT3-CXCR4 axis and reduced bone marrow retention.

• Pol II Degradation Triggers Cell Death Independent of Transc

  2026-08-07

  A recent preprint uncovers that targeted degradation of RNA polymerase II (Pol II) induces cell death through mechanisms not exclusively linked to transcription loss. This discovery refines our understanding of cell death pathways and presents important implications for cancer research and the study of regulated apoptosis.

• Drug-Sensitized Yeast Platform for mTOR Inhibitor Discovery

  2026-08-06

  A recent study introduces a drug-sensitized yeast system that substantially increases the sensitivity and specificity of detecting mTOR inhibitors, overcoming several limitations of traditional screening methods. This platform has direct implications for aging, metabolic, and cancer research, and provides a valuable benchmark for distinguishing compound selectivity in the context of glucose metabolism and diabetes research.

• Monomeric Amyloid Beta Regulates Microglia and Brain Develop

  2026-08-06

  Kwon et al. (2024) reveal a previously unrecognized signaling pathway in which monomeric amyloid beta (Aβ) directly inhibits microglial activation during mouse cortical development. This finding reframes the physiological role of Aβ, with implications for understanding both normal brain assembly and the neuroimmune mechanisms underlying Alzheimer's disease.

• Salvianolic Acid B: Redefining Antifibrotic Strategy in Pulm

  2026-08-05

  Explore how Salvianolic acid B, a polyphenolic compound from Salvia miltiorrhiza, is transforming the landscape of pulmonary fibrosis research through targeted inhibition of lysyl hydroxylase 2 (LH2). This thought-leadership article provides mechanistic insights, experimental guidance, and strategic perspectives for translational researchers seeking next-generation antifibrotic solutions.

• 2,2,2-Trichloroethanol: Small Molecule Biochemical for Prote

  2026-08-05

  2,2,2-Trichloroethanol is a high-purity small molecule biochemical widely used as a protein analysis reagent. Its solubility and stability enable precise molecular biology research, as verified by both APExBIO and peer-reviewed literature. This article clarifies its mechanism, benchmarks, and workflow integration with evidence-based guidance.

• In Silico Peptide Screening for β-Lactamase Inhibitor Discov

  2026-08-04

  Xu et al. introduce MDockPeP2_VS, an automated in silico peptide screening platform, enabling rapid identification of protein-binding peptides targeting antibiotic resistance enzymes such as TEM-1 β-lactamase. Their approach substantially reduces the computational search space, achieving practical and potent peptide inhibitor discovery.

• Ruxolitinib Phosphate: Unlocking Next-Gen Strategies in Tran

  2026-08-04

  This thought-leadership article explores how Ruxolitinib phosphate (INCB018424)—a selective JAK1/JAK2 inhibitor—bridges mechanistic cancer biology and advanced translational research. By integrating the latest mechanistic findings, including its impact on mitochondrial dynamics and cell death in anaplastic thyroid cancer, with strategic guidance on experimental design, this piece delivers actionable insights for researchers aiming to model autoimmune, inflammatory, and oncologic diseases. The article positions Ruxolitinib phosphate as an indispensable investigative tool, offering evidence-backed recommendations and outlining future research directions.

• Bismuth Subsalicylate: Precision in GI Research & Apoptosis

  2026-08-03

  Discover how Bismuth Subsalicylate empowers gastrointestinal disorder research and apoptosis assay development. This deep dive explores unique mechanistic insights and advanced protocol considerations, setting it apart in the field.

• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-08-03

  This study details the rational design and characterization of new allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), presenting compound 8c as a metabolically stable and orally viable candidate that improves glucose tolerance and mitigates allergic and cancer-related processes in preclinical models. These findings offer a new therapeutic scaffold for metabolic, allergic, and oncological disorders involving PDK4 dysregulation.

• Cy5 NHS ester(Et): Technical Guide for Fluorescent Labeling

  2026-08-02

  Cy5 NHS ester(Et) enables efficient, water-soluble fluorescent labeling of primary amines in proteins and biomolecules, supporting precise detection in immunofluorescence, flow cytometry, and fluorescence microscopy workflows. It is not suitable for ethanol-based protocols or for situations requiring long-term storage of dissolved dye solutions. This technical guide provides actionable parameters and troubleshooting steps for reliable use.

• PA-824: Advanced Protocols for Mycobacterium tuberculosis Re

  2026-08-01

  Leverage PA-824, a potent bicyclic nitroimidazole derivative, to streamline tuberculosis research with reproducible, dual-action bactericidal workflows. This guide delivers actionable protocol enhancements, synergy-driven assay strategies, and troubleshooting insights grounded in the latest mechanistic evidence.

• Torin2: Precision mTOR Inhibitor Optimizing Cancer Research

  2026-07-31

  Torin2 sets a new standard among mTOR inhibitors, offering exquisite selectivity and robust performance in both in vitro and in vivo cancer models. This guide details optimized protocols, troubleshooting strategies, and practical insights that translate recent mechanistic breakthroughs into high-impact experimental design.

• Antipyrine in CNS Drug Discovery: Applied Workflows & Troubl

  2026-07-31

  Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) is a gold standard for benchmarking blood-brain barrier (BBB) permeability and pharmacokinetic workflows. This article details stepwise protocols and advanced strategies to maximize reproducibility and data quality in CNS drug research using high-purity Antipyrine from APExBIO.

• Salvianolic acid B: Optimizing Pulmonary Fibrosis Research W

  2026-07-30

  Salvianolic acid B (Dan Shen Suan B) stands out as a high-purity, research-grade antifibrotic agent, uniquely targeting lysyl hydroxylase 2 to disrupt collagen cross-linking in pulmonary fibrosis models. This guide translates the latest mechanistic advances and protocol optimizations into actionable workflows for translational scientists.

16745 records 1/1117 page Next 12345 下5页 Last page